Back to Search

JASON SHOHET, MD

MD

Pediatric Hematology & Oncology Physician

NPI: 1821178260Individual

Specialties, Licenses & Credentials

Pediatrics Physician

Pediatrics

Code: 208000000X

159613(MA)
Pediatric Hematology & Oncology PhysicianPrimary

Pediatrics — Pediatric Hematology-Oncology

Code: 2080P0207X

K9419(TX)159613(MA)

Research & Publications (16)

Mdm2 deficiency suppresses MYCN-Driven neuroblastoma tumorigenesis in vivo.
PMID 19649205·Neoplasia·2009
7-preclinical
An inner medullary concentrating process actuated by renal pelvic/calyceal muscle contractions: assessment and hypothesis.
PMID 19590248·Nephron Physiol·2009
7-preclinical
The MYCN oncogene is a direct target of miR-34a.
PMID 18504438·Oncogene·2008
8-other
MYCN-directed centrosome amplification requires MDM2-mediated suppression of p53 activity in neuroblastoma cells.
PMID 17363562·Cancer Res·2007
8-other
MDM2 inhibition sensitizes neuroblastoma to chemotherapy-induced apoptotic cell death.
PMID 16985070·Mol Cancer Ther·2006
7-preclinical
Two fluid compartments in the renal inner medulla: a view through the keyhole of the concentrating process.
PMID 16766360·Philos Trans A Math Phys Eng Sci·2006
7-preclinical
Deregulated minichromosomal maintenance protein MCM7 contributes to oncogene driven tumorigenesis.
PMID 16518415·Oncogene·2006
4-observational
MDM2 as MYCN transcriptional target: implications for neuroblastoma pathogenesis.
PMID 15927364·Cancer Lett·2005
6-review
MDM2 as a critical effector of the MYCN oncogene in tumorigenesis.
PMID 15917661·Cell Cycle·2005
7-preclinical
Anti-gene peptide nucleic acid specifically inhibits MYCN expression in human neuroblastoma cells leading to cell growth inhibition and apoptosis.
PMID 15897242·Mol Cancer Ther·2005
8-other
Gene profiling of high risk neuroblastoma.
PMID 15706435·World J Surg·2005
6-review
The p53 regulatory gene MDM2 is a direct transcriptional target of MYCN in neuroblastoma.
PMID 15644444·Proc Natl Acad Sci U S A·2005
8-other
The management of pediatric cholesteatoma.
PMID 12487085·Otolaryngol Clin North Am·2002
6-review
Mode locking in reversed-field pinch experiments.
PMID 12059371·Phys Rev Lett·2002
8-other
Minichromosome maintenance protein MCM7 is a direct target of the MYCN transcription factor in neuroblastoma.
PMID 11861392·Cancer Res·2002
8-other
Neurotologic follow-up after radiation of posterior fossa tumors.
PMID 10733194·Am J Otol·2000
5-case

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Via practice · 5 locations total

Address
4845 ALAMEDA AVE
EL PASO, TX 79905

Locations (5)

Practice Location

4845 ALAMEDA AVE, EL PASO, TX
(915) 298-5444

Practice Location

5400 ALAMEDA AVE BLDG B, EL PASO, TX
(915) 242-8402

Practice Location

6701 FANNIN ST, HOUSTON, TX
(832) 822-4240

Practice Location

55 LAKE AVE N, WORCESTER, MA
(774) 441-8083

Practice Location

55 LAKE AVE N, WORCESTER, MA
(508) 856-4225

Quick Facts

NPI
1821178260
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
3
Locations
5
Publications
16

Are you this provider?

Claim Your Profile